These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 21846440)
1. Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer. Pinar Cilesiz Goksedef B; Gorgen H; Baran SY; Api M; Cetin A J Obstet Gynaecol Can; 2011 Aug; 33(8):844-850. PubMed ID: 21846440 [TBL] [Abstract][Full Text] [Related]
2. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229 [TBL] [Abstract][Full Text] [Related]
3. What is the predictive value of preoperative CA 125 level on the survival rate of type 1 endometrial cancer? Yilmaz Baran Ş; Alemdaroğlu S; Doğan Durdağ G; Yüksel Şimşek S; Bolat F; Köse F; Çelik H Turk J Med Sci; 2021 Feb; 51(1):335-341. PubMed ID: 32979897 [TBL] [Abstract][Full Text] [Related]
4. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer. Lee J; Kong TW; Paek J; Chang SJ; Ryu HS Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus. Sarı ME; Meydanlı MM; Yalçın I; Şahin H; Çoban G; Çelik H; Kuşçu E; Gungor T; Ayhan A Oncol Res Treat; 2018; 41(12):750-754. PubMed ID: 30419557 [TBL] [Abstract][Full Text] [Related]
6. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status. O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897 [TBL] [Abstract][Full Text] [Related]
7. Preoperative Pelvic MRI and Serum Cancer Antigen-125: Selecting Women With Grade 1 Endometrial Cancer for Lymphadenectomy. Sadowski EA; Robbins JB; Guite K; Patel-Lippmann K; Munoz del Rio A; Kushner DM; Al-Niaimi A AJR Am J Roentgenol; 2015 Nov; 205(5):W556-64. PubMed ID: 26496578 [TBL] [Abstract][Full Text] [Related]
8. The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer. Atguden Z; Yildiz A; Aksut H; Yalcin SE; Yalcin Y; Uysal D; Yetimalar H Asian Pac J Cancer Prev; 2016; 17(2):497-501. PubMed ID: 26925634 [TBL] [Abstract][Full Text] [Related]
9. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer. Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study. Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245 [TBL] [Abstract][Full Text] [Related]
11. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Suh DH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Kang SB Eur J Obstet Gynecol Reprod Biol; 2012 Jun; 162(2):206-10. PubMed ID: 22445206 [TBL] [Abstract][Full Text] [Related]
12. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related]
13. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study. Kang S; Kang WD; Chung HH; Jeong DH; Seo SS; Lee JM; Lee JK; Kim JW; Kim SM; Park SY; Kim KT J Clin Oncol; 2012 Apr; 30(12):1329-34. PubMed ID: 22412131 [TBL] [Abstract][Full Text] [Related]
14. Value of circulating tumor cells positive for thyroid transcription factor-1 (TTF-1) to predict recurrence and survival rates for endometrial carcinoma. Zhang Y; Qu X; Qu PP J BUON; 2016; 21(6):1491-1495. PubMed ID: 28039713 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer. Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890 [TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma. Yildiz A; Yetimalar H; Kasap B; Aydin C; Tatar S; Soylu F; Yildiz FS Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):191-5. PubMed ID: 22727919 [TBL] [Abstract][Full Text] [Related]
18. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer. Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586 [TBL] [Abstract][Full Text] [Related]
20. Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study. Kang S; Nam JH; Bae DS; Kim JW; Kim MH; Chen X; No JH; Lee JM; Kim JH; Watari H; Kim SM; Kim SH; Seong SJ; Kim KT; Kim SC; Kim JH; Lim MC; Lee JY; Ryu SY; Yang B; Kim BG Cancer; 2017 Jan; 123(2):263-272. PubMed ID: 28067948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]